Stoke Therapeutics Appoints Julie Anne Smith to its Board of Directors - businesswire.com -BoardProspects

Stoke Therapeutics Appoints Julie Anne Smith to its Board of Directors

businesswire.com Jun 4 2020 BoardMoves

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc., (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the appointment of Julie Anne Smith to its Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- USA Technologies’ Board of Director Nominees Underscore Company’s Commitment to Excellence and Superior Performance also published in businesswire.com
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Alexion Pharmaceuticals, Inc. (NASDAQ: Alxn) Names Francois Nader to Board of Directors also mentions Alexion Pharmaceuticals
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- BMC’s Independent, Experienced Board Overseeing Continued Growth and Value Creation also published in businesswire.com

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. This is an exciting time for Stoke as it transitions to a clinical stage company and looks to the future.
Topics Mentioned